LOBEFARO, RICCARDO
LOBEFARO, RICCARDO
Universita' degli Studi di MILANO
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma : Myth or Reality?
2020 E. Dell'Aquila, T. Zeppola, M. Stellato, F. Pantano, M. Scartozzi, C. Madaudo, F. Pietrantonio, C. Cremolini, G. Aprile, B. Vincenzi, R. Moretto, M. Puzzoni, S. Garattini, R. Lobefaro, G. Tonini, D. Santini
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer
2019 F. Pietrantonio, R. Lobefaro, M. Antista, S. Lonardi, A. Raimondi, F. Morano, S. Mosconi, L. Rimassa, S. Murgioni, A. Sartore-Bianchi, G. Tomasello, R. Longarini, G. Farina, F. Petrelli, S. Gori, G. Randon, S. Corallo, F. Pagani, V. Guarini, F. Palermo, A. Martinetti, M. Macagno, L. Barault, F. Perrone, E. Tamborini, M. Milione, F. Di Nicolantonio, M. Di Maio, G. Fucà, M. Di Bartolomeo, F. de Braud
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin
2022 E. Zattarin, F. Nichetti, F. Ligorio, L. Mazzeo, R. Lobefaro, G. Fuca, G. Peverelli, A. Vingiani, G. Bianchi, V, G. Capri, F. de Braud, C. Vernieri
Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial
2022 F. Ligorio, G. Fucà, L. Provenzano, R. Lobefaro, L. Zanenga, A. Vingiani, A. Belfiore, A. Lorenzoni, A. Alessi, G. Pruneri, F. de Braud, C. Vernieri
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications
2020 E. Zattarin, R. Leporati, F. Ligorio, R. Lobefaro, A. Vingiani, G. Pruneri, C. Vernieri
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology
2022 S. Manglaviti, M. Brambilla, D. Signorelli, R. Ferrara, G. Lo Russo, C. Proto, G. Galli, A. De Toma, M. Occhipinti, G. Viscardi, T. Beninato, E. Zattarin, M. Bini, R. Lobefaro, G. Massa, A. Bottiglieri, G. Apollonio, E. Sottotetti, R.M. Di Mauro, B. Trevisan, M. Ganzinelli, A. Fabbri, F.G.M. de Braud, M.C. Garassino, A. Prelaj
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers
2021 R. Lobefaro, G. Viscardi, R. Di Liello, G. Massa, M.L. Iacovino, F. Sparano, C.M. Della Corte, R. Ferrara, D. Signorelli, C. Proto, A. Prelaj, G. Galli, A. De Toma, M. Brambilla, M. Ganzinelli, B. Trevisan, F. Ciardiello, F. De Braud, F. Morgillo, M.C. Garassino, G. Lo Russo
PillarX: A Microfluidic Device to Profile Circulating Tumor Cell Clusters Based on Geometry, Deformability, and Epithelial State
2022 B.J. Green, M. Marazzini, B. Hershey, A. Fardin, Q. Li, Z. Wang, G. Giangreco, F. Pisati, S. Marchesi, A. Disanza, E. Frittoli, E. Martini, S. Magni, G.V. Beznoussenko, C. Vernieri, R. Lobefaro, D. Parazzoli, P. Maiuri, K. Havas, M. Labib, S. Sigismund, P.P.D. Fiore, R.H. Gunby, S.O. Kelley, G. Scita
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program
2021 A. Prelaj, A. Bottiglieri, C. Proto, G. Lo Russo, D. Signorelli, R. Ferrara, G. Galli, A. De Toma, G. Viscardi, M. Brambilla, R. Lobefaro, F. Nichetti, S. Manglaviti, M. Occhipinti, A. Labianca, M. Ganzinelli, R. Gallucci, N. Zilembo, G.F. Greco, V. Torri, F. de Braud, M.C. Garassino
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer
2021 F. Ligorio, I. Pellegrini, L. Castagnoli, A. Vingiani, R. Lobefaro, E. Zattarin, M. Santamaria, S.M. Pupa, G. Pruneri, F. de Braud, C. Vernieri
The landscape of actionable gene fusions in colorectal cancer
2019 F. Pagani, G. Randon, V. Guarini, A. Raimondi, M. Prisciandaro, R. Lobefaro, M. Di Bartolomeo, G. Sozzi, F. de Braud, P. Gasparini, F. Pietrantonio
The pan-immune-inflammation-value predicts the survival of patients with human epidermal growth factor receptor 2 (Her2)—positive advanced breast cancer treated with first-line taxane-trastuzumab-pertuzumab
2021 F. Ligorio, G. Fuca, E. Zattarin, R. Lobefaro, L. Zambelli, R. Leporati, C. Rea, G. Mariani, G.V. Bianchi, G. Capri, F. de Braud, C. Vernieri
“Systemic strategy at the patient’s service”: A congress report on supportive care in oncology
2017 F. Nichetti, R. Lobefaro, F. Pagani, G. Randon, F. Corti, F.G.M. DE BRAUD, L. Celio, M. Platania